Market Share of Graft Versus Host Disease Treatment Industry
The Graft Versus Host Disease Treatment market is competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market include Pfizer Inc., Abbvie Inc., Sanofi (Kadmon Pharmaceuticals), Sanofi (Genzyme), Incyte Corporation, Bristol Myers Squibb Company, Genentech Inc., and Astellas Pharma US Inc.
Graft-versus-Host Disease Treatment Market Leaders
Abbvie Inc.
Sanofi
Bristol Myers Squibb Company
Pfizer Inc.
Incyte Corporation
*Disclaimer: Major Players sorted in no particular order